Americhem Expands Medical Grade Materials Compounding Facility

Americhem, Inc. has completed the expansion of their manufacturing facility in Denmark, which includes a clean compounding facility dedicated to medical grade materials. The expansion enhances Americhem’s capabilities to meet increasing European healthcare industry demand for high quality polymer materials.

The new 1,394 sq. m. (15,000 sq. ft.) facility will feature new production lines, quality control labs, offices, customer meeting space, and staff common areas. It will add an additional capacity of 5,000 tons annually, almost doubling the capacity of the existing site. The new clean environment, coupled with Americhem’s ISO 13485:2016 certification that was obtained in early 2023, gives Americhem unique capabilities to produce compounds that meet the most stringent medical device requirements. Additionally, ISO 14644-1:2015 assessment will be performed upon completion of the new production facility and once the first orders have been produced.

Americhem has the ability to fully compound materials such as PP, ABS, PA, PEEK, PC, TPE/TPU, EVA, and POM; all of which can be shipped globally to satisfy OEM’s across the world.

“This investment in Europe follows the acquisition of Controlled Polymers A/S in 2020 and solidifies Americhem’s commitment to not only healthcare, but also Europe.” Said Barto DuPlessis, Americhem’s Managing Director in Europe. The expanded site in Denmark will also serve as Americhem’s headquarters for the European region. This expansion is also a result of the expected double-digit growth within the European healthcare market during the period of 2023-2028. Americhem also sought to have a facility in Europe to keep pace with the ever-changing strict compliance such as REACH regulations that are frequently revised and updated. Increasing requirements for Sustainability compliance adds an additional dimension to regulatory compliance driving the need for further differentiation.